Stage IIIC Ovarian Cancer AJCC v6 and v7 Recruiting Phase 1 / 2 Trials for Carboplatin (DB00958)

DBCOND0093248 (Stage IIIC Ovarian Cancer AJCC v6 and v7)Recruiting1 / 2 IdentifierTitlePurposeDrugs
NCT02726997Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)Treatment
NCT02713386Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerTreatment